Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Purine analogs, antimetabolites antineoplastic

Known as: Purine analogues 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Objective: To review the literature for the treatment of classical and variant hairy cell leukemia (HCL, HCLv), evaluating… Expand
Is this relevant?
2019
2019
Hairy cell leukemia (HCL) is a well-defined entity. Proliferation with hair cells, morphological aspects of hairy cells are easy… Expand
Is this relevant?
Review
2018
Review
2018
Hairy-cell leukaemia (HCL) is a B-cell lymphoproliferative disorder with a distinct morphological, molecular and immunophenotypic… Expand
Is this relevant?
Review
2017
Review
2017
Patients with hairy cell leukaemia (HCL) have highly favourable outcomes after purine analogue therapy. However, most patients… Expand
Is this relevant?
Review
2016
Review
2016
BACKGROUND AND AIMS Tacrolimus is recommended for the treatment of steroid-refractory ulcerative colitis (UC). Concomitantly… Expand
Is this relevant?
2014
2014
BACKGROUND The combination of purine analogues (PA) and rituximab (chemoimmunotherapy) is considered the treatment of choice for… Expand
Is this relevant?
Review
2009
Review
2009
Abstract 3828 Poster Board III-764 Background tMDS/tAML are recognised late complications of chemotherapy and increased risk… Expand
Is this relevant?
2006
2006
AIMS To analyze clinical and laboratory features at presentation in correlation to treatment response and overall survival… Expand
Is this relevant?